Doxorubicin induced heart failure: Phenotype and molecular mechanisms.
about
Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines.Cardiac spheroids as promising in vitro models to study the human heart microenvironment.Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.Development of Metabolic Syndrome Associated to Cancer Therapy: Review.Phthalocyanine induced phototherapy coupled with Doxorubicin; a promising novel treatment for breast cancer.Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway.Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.Cardiotoxicity of Anticancer Therapeutics.Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats.Protective Effect of Dietary Ghrelin-Containing Salmon Stomach Extract on Mortality and Cardiotoxicity in Doxorubicin-Induced Mouse Model of Heart Failure.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.Sex Differences in Cancer: Epidemiology, Genetics and Therapy.Perturbation of microRNA signalling by doxorubicin in spermatogonial, Leydig and Sertoli cell lines
P2860
Q33853732-71281DA7-832B-4ABB-B72B-F4056FBC2CA1Q36204410-9AEFD5E2-3002-4326-9C78-9C8767BD4FA3Q38647934-6D9D6ABD-5B2C-4548-BADC-522F6CEAB8BBQ38698082-682079FE-8F47-4CFA-833A-6179A1C54B3DQ38700491-5A9B3D15-7E4F-4856-9B50-CD0CA65433ADQ38972507-99988D0C-7A9F-4436-AA1D-40E48278D4B0Q39402117-AA9EE830-713D-49B3-9971-429A58F07DAEQ46039967-776EFF5C-8658-43E6-A842-4DB42917334EQ47303605-A5B52B2F-E8C8-4866-A144-6231C3F272C4Q49706717-B998BD03-EE53-44E5-AC30-0AFD967EC953Q50326869-9753DF57-A8D9-41C8-B79C-2F5B31C25EC0Q50420344-0063258B-3B98-4775-AAFA-160E3677D9F1Q50948084-74D848B4-12BF-43B8-97C7-C792D2320C39Q53807749-39EFE5C5-9913-4299-8170-DEEBA6751D51Q54959206-50B37291-19DC-497B-884C-1F3F25396973Q55406137-423DCE32-E6AD-41D6-BFB8-04DA0958D0BCQ57497532-836B3821-AE7D-49B9-98EB-BF4A6ADC21D2
P2860
Doxorubicin induced heart failure: Phenotype and molecular mechanisms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Doxorubicin induced heart failure: Phenotype and molecular mechanisms.
@en
type
label
Doxorubicin induced heart failure: Phenotype and molecular mechanisms.
@en
prefLabel
Doxorubicin induced heart failure: Phenotype and molecular mechanisms.
@en
P2860
P1476
Doxorubicin induced heart failure: Phenotype and molecular mechanisms
@en
P2093
Maria A Mitry
P2860
P356
10.1016/J.IJCHA.2015.11.004
P577
2016-03-01T00:00:00Z